Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||
5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -9.05 | -9.09 | -9.47 | 40.72% | CHEMBL602674 |
5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -9.12 | -9.20 | N/A | 53.38% | CHEMBL3358494 |
5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -8.44 | -9.24 | -9.18 | 56.41% | CHEMBL1455766 |
5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -8.80 | -8.97 | N/A | 51.82% | CHEMBL496739 |
AA1R_HUMAN | adenosine A1 receptor | -8.60 | -8.43 | -8.95 | 40.44% | CHEMBL164457 |
AA2AR_HUMAN | adenosine A2a receptor | -8.03 | -8.12 | -8.85 | 40.44% | CHEMBL164457 |
ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.99 | -9.57 | -7.67 | 40.31% | CHEMBL155392 |
ACE_HUMAN | angiotensin I converting enzyme | -9.19 | -8.06 | -7.66 | 38.69% | CHEMBL2112767 |
ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -6.66 | N/A | N/A | 23.90% | CHEMBL386114 |
ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -5.10 | -9.30 | -5.06 | N/A | N/A |
ACM1_HUMAN | cholinergic receptor muscarinic 1 | -5.43 | 5.38 | N/A | 56.41% | CHEMBL1455766 |
ACM4_HUMAN | cholinergic receptor muscarinic 4 | -7.42 | -8.96 | N/A | 56.41% | CHEMBL1455766 |
ADRB2_HUMAN | adrenoceptor beta 2 | -8.10 | -8.96 | -9.61 | 49.13% | CHEMBL1348147 |
AGTR2_HUMAN | angiotensin II receptor type 2 | -8.73 | -8.28 | -8.05 | 35.75% | CHEMBL36324 |
ALDR_HUMAN | aldo-keto reductase family 1 member B | -9.00 | -9.35 | -8.97 | 38.52% | CHEMBL282245 |
AMPN_HUMAN | alanyl aminopeptidase, membrane | -9.49 | -9.52 | -8.44 | 29.76% | CHEMBL1077590 |
AOFA_HUMAN | monoamine oxidase A | -9.88 | -10.30 | -9.88 | 38.51% | CHEMBL1814057 |
AOFB_HUMAN | monoamine oxidase B | -10.08 | -10.08 | -10.16 | 37.38% | CHEMBL338404 |
BACE1_HUMAN | beta-secretase 1 | -7.43 | -7.25 | -8.05 | 40.00% | CHEMBL202507 |
CAH2_HUMAN | carbonic anhydrase 2 | -7.82 | -7.96 | -8.19 | 60.00% | CHEMBL431742 |
CASP1_HUMAN | caspase 1 | -7.38 | -6.80 | -7.06 | 41.55% | CHEMBL114830 |
CDK5_HUMAN | cyclin dependent kinase 5 | -7.44 | -8.13 | -9.19 | 35.71% | CHEMBL1990254 |
CHLE_HUMAN | butyrylcholinesterase | -8.58 | -8.22 | -8.83 | 34.38% | CHEMBL3752555 |
CNR1_HUMAN | cannabinoid receptor 1 | -8.27 | -11.31 | -9.23 | 55.92% | CHEMBL428779 |
CNR2_HUMAN | cannabinoid receptor 2 | -8.88 | -8.85 | N/A | 54.81% | CHEMBL2336536 |
COLI_HUMAN | proopiomelanocortin | -9.32 | -9.88 | -8.35 | N/A | N/A |
COMT_HUMAN | catechol-O-methyltransferase | -6.48 | -6.02 | -6.22 | 25.53% | CHEMBL3818719 |
CRP_HUMAN | C-reactive protein | -6.87 | -6.18 | N/A | N/A | N/A |
CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -1.26 | N/A | N/A | 33.33% | CHEMBL253921 |
CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -8.45 | -7.51 | -8.10 | 40.00% | CHEMBL3627798 |
DRD2_HUMAN | dopamine receptor D2 | -8.88 | N/A | N/A | 53.38% | CHEMBL3596212 |
DRD3_HUMAN | dopamine receptor D3 | -9.25 | N/A | N/A | 60.50% | CHEMBL3358106 |
DRD4_HUMAN | dopamine receptor D4 | -9.69 | -9.91 | N/A | 48.65% | CHEMBL139926 |
EDN1_HUMAN | endothelin 1 | -7.73 | N/A | N/A | N/A | N/A |
ESR1_HUMAN | estrogen receptor 1 | -6.58 | -7.38 | -7.49 | 39.75% | CHEMBL3916398 |
FABP5_HUMAN | fatty acid binding protein 5 | -6.11 | -6.32 | -6.42 | 18.78% | CHEMBL3950316 |
FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -8.31 | N/A | N/A | 34.85% | CHEMBL1988141 |
GLRA3_HUMAN | glycine receptor alpha 3 | -8.40 | -8.45 | -8.46 | 26.17% | CHEMBL4074873 |
GLRA3_HUMAN | glycine receptor alpha 3 | -9.08 | N/A | N/A | 26.17% | CHEMBL4074873 |
GRM5_HUMAN | glutamate metabotropic receptor 5 | -8.16 | -5.02 | -4.56 | 39.61% | CHEMBL551894 |
HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.57 | -8.50 | -8.25 | 49.35% | CHEMBL3698273 |
HRH1_HUMAN | histamine receptor H1 | -8.04 | N/A | N/A | 56.41% | CHEMBL1455766 |
HYES_HUMAN | epoxide hydrolase 2 | -8.83 | -8.93 | -8.79 | 54.72% | CHEMBL381544 |
IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -8.51 | N/A | N/A | 37.97% | CHEMBL2375685 |
MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -8.17 | -8.58 | N/A | 43.56% | CHEMBL2 |
MIF_HUMAN | macrophage migration inhibitory factor | -7.20 | -7.13 | -6.06 | 38.89% | CHEMBL3409229 |
MK01_HUMAN | mitogen-activated protein kinase 1 | -7.26 | -7.81 | -7.50 | 35.71% | CHEMBL1990254 |
MK03_HUMAN | mitogen-activated protein kinase 3 | -8.45 | -8.76 | -7.92 | 29.45% | CHEMBL3798109 |
MTOR_HUMAN | mechanistic target of rapamycin kinase | -9.09 | -9.02 | -8.75 | 36.46% | CHEMBL3670249 |
NEP_HUMAN | membrane metalloendopeptidase | -7.89 | -7.62 | -8.13 | 39.64% | CHEMBL3677674 |
NK1R_HUMAN | tachykinin receptor 1 | -8.38 | -7.98 | -8.11 | 37.58% | CHEMBL319653 |
NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -8.29 | -8.46 | -8.37 | 31.13% | CHEMBL2333945 |
NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -9.41 | -9.53 | -8.39 | 29.28% | CHEMBL2013206 |
NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -7.39 | -8.45 | -8.37 | 27.46% | CHEMBL159739 |
NOS1_HUMAN | nitric oxide synthase 1 | -9.55 | -9.52 | -9.81 | 34.59% | CHEMBL96680 |
NOS2_HUMAN | nitric oxide synthase 2 | -8.34 | -9.90 | -3.74 | 38.89% | CHEMBL490886 |
NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -9.42 | -9.53 | -8.78 | 34.85% | CHEMBL1988141 |
OPRD_HUMAN | opioid receptor delta 1 | -7.37 | -6.48 | -7.71 | 51.75% | CHEMBL339621 |
OPRK_HUMAN | opioid receptor kappa 1 | -9.03 | -8.35 | -8.17 | 56.41% | CHEMBL1713967 |
OPRM_MOUSE | Mu-type opioid receptor | -8.27 | -8.05 | N/A | 43.48% | CHEMBL186281 |
OPRX_HUMAN | opioid related nociceptin receptor 1 | -8.09 | -7.47 | -8.29 | 33.33% | CHEMBL257921 |
P2RX3_HUMAN | purinergic receptor P2X 3 | -6.31 | -6.28 | -6.30 | 32.84% | CHEMBL3679809 |
P2Y12_HUMAN | purinergic receptor P2Y12 | -9.22 | -6.26 | -8.86 | 35.35% | CHEMBL591212 |
PAR1_HUMAN | coagulation factor II thrombin receptor | -7.24 | N/A | N/A | 54.81% | CHEMBL1270824 |
PDE4B_HUMAN | phosphodiesterase 4B | -9.39 | -9.54 | -9.54 | 30.06% | CHEMBL383225 |
PDE5A_HUMAN | phosphodiesterase 5A | -9.51 | -9.63 | -9.12 | 33.33% | CHEMBL334903 |
PERM_HUMAN | myeloperoxidase | -7.60 | -7.62 | -7.52 | 32.85% | CHEMBL86 |
PGH1_SHEEP | Prostaglandin G/H synthase 1 | -7.80 | -8.94 | -7.61 | 40.48% | CHEMBL268643 |
PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -3.16 | -4.58 | -7.15 | 36.93% | CHEMBL271551 |
PPAP_HUMAN | acid phosphatase 3 | -8.30 | N/A | N/A | 23.62% | CHEMBL498632 |
PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -8.40 | -9.49 | -8.39 | 42.11% | CHEMBL1085795 |
PRGR_HUMAN | progesterone receptor | -4.59 | -2.87 | -6.84 | 31.21% | CHEMBL1163630 |
PTGES_HUMAN | prostaglandin E synthase | -6.84 | N/A | N/A | 41.61% | CHEMBL3092271 |
SC6A4_HUMAN | solute carrier family 6 member 4 | -9.48 | -10.14 | -10.10 | 48.89% | CHEMBL3612827 |
SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -7.74 | N/A | N/A | 38.69% | CHEMBL426790 |
TLR4_HUMAN | toll like receptor 4 | -7.37 | -7.71 | -7.66 | 25.50% | CHEMBL2419466 |
TNFA_HUMAN | tumor necrosis factor | -8.06 | N/A | N/A | 36.73% | CHEMBL11440 |
TRBM_HUMAN | thrombomodulin | -7.86 | -6.90 | N/A | N/A | N/A |
TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -6.99 | -8.29 | N/A | N/A | N/A |
TRPM8_FICAL | Uncharacterized protein | -9.16 | N/A | N/A | N/A | N/A |
TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -8.69 | N/A | N/A | 34.62% | CHEMBL185683 |
TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -8.57 | -8.02 | N/A | N/A | N/A |
TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -6.61 | -6.96 | N/A | 25.00% | CHEMBL3696375 |
TRXR1_HUMAN | thioredoxin reductase 1 | -7.60 | -8.20 | -6.87 | N/A | N/A |
TRY1_HUMAN | serine protease 1 | -6.84 | N/A | N/A | 43.31% | CHEMBL156858 |